Dyne Therapeutics Inc (DYN) Event Aug. 04, 2022, 00:00 UTC (61% Neutral) Dyne Therapeutics, Inc. (DYN) Reports Net Loss for 2022-06-30 Full text
Register to leave comments News bot Oct. 29, 2025, 10:55 a.m. 🏢 Dyne Therapeutics Inc (DYN) - Form 10-Q Quarterly Report Quarterly financial filing submitted to the SEC 📋 Filing Information 📄 Form Type: 10-Q 📅 Filing Date: 2022-08-04 📊 Period of Report: 2022-06-30 ⏰ Accepted: N/A 📊 Key Financial Metrics (Period-over-Period Comparison) Metric Current Period Previous Period Change ($) Change (%) Trend Net Income/Loss $-29.95M $-29.95M N/A +0.00% ➡️ Total Assets $425.66M $340.03M $85.64M +25.19% 📈 Total Liabilities $57.47M $52.97M $4.50M +8.49% 📉 Stockholders' Equity $452.60M $-134.11M $586.70M +437.49% 📈 Operating Income/Loss $-55.30M $-88.54M $33.24M +37.54% 📉 R&D Expense $42.50M $74.90M $-32.40M -43.26% 📈 Earningspersharebasic $-1.09 $-1.70 $0.61 +35.88% 📈 Earningspersharediluted $-1.09 $-1.70 $0.61 +35.88% 📈 📈 Financial Trend Analysis 🔻 Reported net loss for the period • 🏦 Strengthened balance sheet with assets growing faster than liabilities 📎 View Full 10-Q Filing on SEC.gov Access the complete official filing document
🏢 Dyne Therapeutics Inc (DYN) - Form 10-Q Quarterly Report
📋 Filing Information
Key Financial Metrics (Period-over-Period Comparison)
Financial Trend Analysis
🔻 Reported net loss for the period • 🏦 Strengthened balance sheet with assets growing faster than liabilities
📎 View Full 10-Q Filing on SEC.gov
Access the complete official filing document